인간 제대혈액에서 유래된 중간엽 줄기세포의 신경 및 콜린성 분화
Neural and cholinergic differentiation of mesenchymal stem cells derived from the human umbilical cord blood
2
조회
0
다운로드
0
인용
0
참고문헌
초록
인간 제대혈 세포는 조혈모세포, 중간엽 줄기세포와 내피전구세포를 풍부하게 포함하고 있다. 인간 제대혈 속의 중간엽 줄기세포는 조혈모세포와는 달리 다능성 줄기세포이며 신경세포로 분화할 수 있는 잠재성을 가지고 있다. 본 연구에서는 세포배양을 통해 제대혈의 중간엽 줄기세포를 신경세포와 콜린성 신경세포로 분화를 유도 하였다. 중간엽 줄기세포를 신경세포로 분화시키기 위해 배양액에 dimethyl sulphoxide(DMSO)와 butylated hydroxyanisole(BHA)를 첨가하여 유도하였으며 basic fibroblast growth factor(bFGF), retinoic acid(RA), sonic hedgehog(Shh)를 처리하여 콜린성 신경세포로 분화시켰다. DMSO와 BHA에 처리된 중간엽 줄기세포가 빠르게 신경세포 모양으로 분화하는 것을 관찰하였으며, 이것은 면역조직학적 염색에서 신경세포 특이 표지인 β-tubulin III, 별아교세포에 대한 특이 표지인 GFAP, 희돌기아교세포에 대한 특이 표지인 Gal-C에 대해 양성반응을 나타내었고, 그 비율은 각각 32.3±2.9%, 11.0±0.9%, 9.4±1.0% 였다. RT-PCR 분석에서 배양 단계에 따라 신경세포에 특이적인 표지 인자가 발현됨을 통해, 중간엽 줄기세포가 신경세포로 분화됨을 확인하였다. 또한, 중간엽 줄기세포에 bFGF, RA, Shh를 처리하여 콜린성 신경세포로 분화시켰을 때, 전체 중간엽 세포 중 31.3±3.2%가 신경세포 특이 표지인 β-tubulin III에 양성반응을 보였으며 이들 세포 중 70.0±7.8%가 콜린성 신경 특이 표지인 ChAT에 양성반응을 보였고, 이것은 Woodbury방법에 의한 신경분화의 경우보다 3배 가량 높은 비율로 콜린성 신경의 분화를 유도한 것이다. 이러한 실험 결과들은 인간 제대혈의 중간엽 줄기세포가 콜린성 신경세포로 분화가 가능하고 이러한 잠재성을 가진 제대혈 중간엽 줄기세포는 퇴행성 신경질환에 대한 세포 치료제로서 가능성을 제시한다.
Abstract
Human umbilical cord blood(HUCB) contains a rich source of hematopoietic stem cells, mesenchymal stem cells and endothelial cell precursors. Mesenchymal stem cells(MSCs) in HUCB are multipotent stem cells, differ from hematopoietic stem cells and can be differentiated into neural cells. We studied on transdifferentiation-promoting conditions in neural cells and cholinergic neuron induction of HUCB-derived MSCs. Neural differentiation was induced by adding dimethyl sulphoxide(DMSO) and butylated hydroxyanisole(BHA) in Dulbeco's Modified Essential Medium(DMEM) and fetal bovine serum(FBS). Differentiation of MSCs to cholinergic neurons was induced by combined treatment with basic fibroblast growth factor(bFGF), retinoic acid(RA) and sonic hedgehog(Shh). MSCs treated with DMSO and BHA rapidly assumed the morphology of multipolar neurons. Both immunocytochemistry and RT-PCR analysis indicated that the expression of a number of neural markers including β-tubulin III, GFAP and MBP, was markedly elevated during this acute differentiation. The differentiation rate was about 32.3±2.9% for β-tubulin III-positive cells, 11.0±0.9% for GFAP, and 9.4±1.0% for Gal-C. HUCB-MSCs treated combinatorially with bFGF, RA and Shh were differentiated into cholinergic neurons. After cholinergic neuronal differentiation, the β-tubulin III-positive cell population of total cells was 31.3±3.2% and of differentiated neuronal population, 70.0±7.8% was ChAT-positive showing 3 folds higher in cholinergic population than neural induction. Conclusively, HUCB-derived MSCs can be differentiated into neural and cholinergic neurons and these findings suggest that HUCB are alternative cell source of treatment for neurodegenerative diseases such as Alzheimer's disease.
참고문헌 (27)
- "Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease", pp.101~108 (1983)
- "Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice", 21, pp.1200~1207 (2003)
- "Proneural genes and the specification of neural cell types", 3, pp.517~530 (2002)
- "Human cord blood-derived cells attain neuronal and glial features in vitro", 115, pp.2131~2138 (2002)
- "Potential of mesenchymal stem cell therapy", 19, pp.650~655 (2007)
- "Interest of cord blood stem cells", 55, pp.195~200 (2001)
- "A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res 288", pp.213~218 (1983)
- "Stem cells: classifications, controversies, and clinical applications", 34, pp.415~423 (2005)
- "The potential of cord blood stem cells for use in regenerative medicine", 7, pp.1311~1322 (2007)
- "Retinoic acid-mediated induction of neurons and glial cells from human umbilical cord-derived hematopoietic stem cells", 75, pp.573~584 (2004)
- "Rapid neural differentiation of human cord blood-derived mesenchymal stem cells", 15, pp.1731~1734 (2004)
- "Pluripotency of mesenchymal stem cells derived from adult marrow", 418, pp.41~49 (2002)
- "Generation of neural progenitor cells from whole adult bone marrow", 178, pp.288~293 (2002)
- "Directed Differentiation and Transplantation of Human Embryonic Stem Cell-Derived Motoneurons", 25, pp.1931~1939 (2007)
- "Conversion of Xenopus ectoderm into neurons by NeuroD", 268, pp.836~844 (1995)
- "Specification of motoneurons from human embryonic stem cells", 23, pp.215~221 (2005)
- "Stem cell therapy for human neurodegenerative disorders-how to make it work", 10 Suppl, pp.542~550 (2004)
- "Development of adult pluripotent stem cell therapies for ischemic injury and disease", 7, pp.173~184 (2007)
- "Umbilical cord blood stem cells", 18, pp.893~908 (2004)
- "Expression of neural markers in human umbilical cord blood", 171, pp.109~115 (2001)
- "Human motor neuron differentiation from human embryonic stem cells", 14, pp.266~269 (2005)
- "Adult mesenchymal stem cells^cell-based tissue engineering", 5, pp.32~45 (2003)
- "Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert", 102, pp.129~138 (2001)
- "Directed differentiation of embryonic stem cells into motor neurons", 110, pp.385~397 (2002)
- "Adult rat and human bone marrow stromal cells differentiate into neurons", 61, pp.364~370 (2000)
- "Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat", 5, pp.1271~1278 (2002)
- "Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats", 174, pp.11~20 (2002)